Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sadowski

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
European Journal of Endocrinology|March 15, 2017
Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total <sup>68</sup>Ga-DOTATATE-Avid tumor volume measurementsAmit Tirosh, Georgios Z Papadakis, Corina Millo, et al.
Research Square|November 24, 2025
Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical CarcinomaPrachi Mishra, Brieann Sobieski, Dipranjan Laha, et al.
Gastroenterology|November 21, 2017
Prognostic Utility of Total <sup>68</sup>Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine TumorsAmit Tirosh, Georgios Z Papadakis, Corina Millo, et al.
Endocrine-Related Cancer|February 19, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directivesC R C Pieterman, S M Sadowski, J E Maxwell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2022
<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine TumorsA Paden King, Nicholas T Gutsche, Natarajan Raju, et al.
Surgery|November 14, 2018
NIFT-P: Are they indolent tumors? Results of a multi-institutional studyNathalie Chereau, Tristan Greilsamer, Eric Mirallié, et al.
Annals of Surgery|March 7, 2017
Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs EndocrinesFrederic Triponez, Samira M Sadowski, François Pattou, et al.
Neurobiology of Aging|August 30, 2005
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentM J de Leon, S DeSanti, R Zinkowski, et al.
Neuroendocrinology|September 24, 2020
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus StatementBruno Niederle, Andreas Selberherr, Detlef K Bartsch, et al.
Endocrine Oncology (Bristol, England)|January 17, 2025
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirationsPo Hien Ear, Ilaria Marinoni, Talya Dayton, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
European Journal of Endocrinology|March 15, 2017
Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total <sup>68</sup>Ga-DOTATATE-Avid tumor volume measurementsAmit Tirosh, Georgios Z Papadakis, Corina Millo, et al.
Research Square|November 24, 2025
Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical CarcinomaPrachi Mishra, Brieann Sobieski, Dipranjan Laha, et al.
Gastroenterology|November 21, 2017
Prognostic Utility of Total <sup>68</sup>Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine TumorsAmit Tirosh, Georgios Z Papadakis, Corina Millo, et al.
Endocrine-Related Cancer|February 19, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directivesC R C Pieterman, S M Sadowski, J E Maxwell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2022
<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine TumorsA Paden King, Nicholas T Gutsche, Natarajan Raju, et al.
Surgery|November 14, 2018
NIFT-P: Are they indolent tumors? Results of a multi-institutional studyNathalie Chereau, Tristan Greilsamer, Eric Mirallié, et al.
Annals of Surgery|March 7, 2017
Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs EndocrinesFrederic Triponez, Samira M Sadowski, François Pattou, et al.
Neurobiology of Aging|August 30, 2005
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentM J de Leon, S DeSanti, R Zinkowski, et al.
Neuroendocrinology|September 24, 2020
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus StatementBruno Niederle, Andreas Selberherr, Detlef K Bartsch, et al.
Endocrine Oncology (Bristol, England)|January 17, 2025
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirationsPo Hien Ear, Ilaria Marinoni, Talya Dayton, et al.
Pageof 14